New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
09:39 EDTWSTAmgen likely plans to use West's SmartDose, says CL King
CL King says a recent investor presentation from Amgen (AMGN) reviewing evolocumab showed a drug administration device that looks identical to West Pharmaceutical's (WST) SmartDose. As such, the firm has a "very high level of confidence" that Amgen will be using West's SmartDose as one of the administration systems for its PCSK9 inhibitor evolocumab. CL King views the development as a "significant positive" for West and reiterates a Strong Buy rating on the stock with a $58 price target. Shares of West Pharmaceutical are up 3% to $45.56 in early trading.
News For WST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
07:28 EDTWSTWest Pharmaceutical raises FY15 EPS view to $1.74-$1.84 from $1.69-$1.84
Consensus $1.80. Raises FY15 revenue guidance to $1.4B-$1.43B from $1.395B-$1.425B, consensus $1.41B.
07:26 EDTWSTWest Pharmaceutical reports Q2 EPS 47c, consensus 45c
Subscribe for More Information
July 26, 2015
20:03 EDTWSTWest Pharmaceutical eyes Dublin expansion, Irish Independent says
Subscribe for More Information
July 20, 2015
08:05 EDTWSTWest Pharmaceutical expands capabilities at Scottsdale facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use